462 related articles for article (PubMed ID: 10779394)
1. Selective enhancement of beta-adrenergic receptor signaling by overexpression of adenylyl cyclase type 6: colocalization of receptor and adenylyl cyclase in caveolae of cardiac myocytes.
Ostrom RS; Violin JD; Coleman S; Insel PA
Mol Pharmacol; 2000 May; 57(5):1075-9. PubMed ID: 10779394
[TBL] [Abstract][Full Text] [Related]
2. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
Zeiders JL; Seidler FJ; Slotkin TA
J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
[TBL] [Abstract][Full Text] [Related]
3. The role of Gi proteins in reduced vasorelaxation response to beta-adrenoceptor agonists in rat aorta during maturation.
Baloğlu E; Kiziltepe O; Gürdal H
Eur J Pharmacol; 2007 Jun; 564(1-3):167-73. PubMed ID: 17395174
[TBL] [Abstract][Full Text] [Related]
4. Characterization of G-protein signaling in ventricular myocytes from the adult mouse heart: differences from the rat.
Hilal-Dandan R; Kanter JR; Brunton LL
J Mol Cell Cardiol; 2000 Jul; 32(7):1211-21. PubMed ID: 10860764
[TBL] [Abstract][Full Text] [Related]
5. Developmental changes in beta2-adrenergic receptor signaling in ventricular myocytes: the role of Gi proteins and caveolae microdomains.
Rybin VO; Pak E; Alcott S; Steinberg SF
Mol Pharmacol; 2003 Jun; 63(6):1338-48. PubMed ID: 12761344
[TBL] [Abstract][Full Text] [Related]
6. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
[TBL] [Abstract][Full Text] [Related]
7. Beta-adrenoceptor-linked signal transduction in ischemic-reperfused heart and scavenging of oxyradicals.
Persad S; Takeda S; Panagia V; Dhalla NS
J Mol Cell Cardiol; 1997 Feb; 29(2):545-58. PubMed ID: 9140814
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of wild-type Galpha(i)-2 suppresses beta-adrenergic signaling in cardiac myocytes.
Rau T; Nose M; Remmers U; Weil J; Weissmüller A; Davia K; Harding S; Peppel K; Koch WJ; Eschenhagen T
FASEB J; 2003 Mar; 17(3):523-5. PubMed ID: 12631586
[TBL] [Abstract][Full Text] [Related]
9. Adenylyl cyclase isoform-selective regulation of vascular smooth muscle proliferation and cytoskeletal reorganization.
Gros R; Ding Q; Chorazyczewski J; Pickering JG; Limbird LE; Feldman RD
Circ Res; 2006 Oct; 99(8):845-52. PubMed ID: 16973907
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II-evoked enhanced expression of RGS2 attenuates Gi-mediated adenylyl cyclase signaling in A10 cells.
Li Y; Hashim S; Anand-Srivastava MB
Cardiovasc Res; 2005 Jun; 66(3):503-11. PubMed ID: 15914115
[TBL] [Abstract][Full Text] [Related]
11. Beta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins.
Xiao RP
Sci STKE; 2001 Oct; 2001(104):re15. PubMed ID: 11604549
[TBL] [Abstract][Full Text] [Related]
12. Regulation of adenylyl cyclase type VI activity during desensitization of the A2a adenosine receptor-mediated cyclic AMP response: role for protein phosphatase 2A.
Chern Y; Chiou JY; Lai HL; Tsai MH
Mol Pharmacol; 1995 Jul; 48(1):1-8. PubMed ID: 7623763
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide attenuates alpha(2)-adrenergic receptors by ADP-ribosylation of G(i)alpha in ciliary epithelium.
Moroi SE; Hao Y; Sitaramayya A
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2056-62. PubMed ID: 11481272
[TBL] [Abstract][Full Text] [Related]
14. Atrial natriuretic peptide-C receptor-induced attenuation of adenylyl cyclase signaling activates phosphatidylinositol turnover in A10 vascular smooth muscle cells.
Mouawad R; Li Y; Anand-Srivastava MB
Mol Pharmacol; 2004 Apr; 65(4):917-24. PubMed ID: 15044621
[TBL] [Abstract][Full Text] [Related]
15. Modulation of cardiac cyclic AMP metabolism by adenosine receptor agonists and antagonists.
Ma H; Green RD
Mol Pharmacol; 1992 Nov; 42(5):831-7. PubMed ID: 1331765
[TBL] [Abstract][Full Text] [Related]
16. Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR)--but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts.
Xiao RP; Zhang SJ; Chakir K; Avdonin P; Zhu W; Bond RA; Balke CW; Lakatta EG; Cheng H
Circulation; 2003 Sep; 108(13):1633-9. PubMed ID: 12975249
[TBL] [Abstract][Full Text] [Related]
17. Postnatal changes in the G-proteins, cyclic nucleotides and adenylyl cyclase activity in rabbit heart cells.
Kumar R; Joyner RW; Hartzell HC; Ellingsen D; Rishi F; Eaton DC; Lu C; Akita T
J Mol Cell Cardiol; 1994 Dec; 26(12):1537-50. PubMed ID: 7731049
[TBL] [Abstract][Full Text] [Related]
18. RGS2 inhibits beta-adrenergic receptor-induced cardiomyocyte hypertrophy.
Nunn C; Zou MX; Sobiesiak AJ; Roy AA; Kirshenbaum LA; Chidiac P
Cell Signal; 2010 Aug; 22(8):1231-9. PubMed ID: 20362664
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the G protein involved in the muscarinic stimulation of adenylyl cyclase of rat olfactory bulb.
Olianas MC; Onali P
Mol Pharmacol; 1996 Jan; 49(1):22-9. PubMed ID: 8569708
[TBL] [Abstract][Full Text] [Related]
20. Enhanced cardiac L-type calcium current response to beta2-adrenergic stimulation in heart failure.
Zhang ZS; Cheng HJ; Ukai T; Tachibana H; Cheng CP
J Pharmacol Exp Ther; 2001 Jul; 298(1):188-96. PubMed ID: 11408541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
